Open Forum Infectious Diseases (ISSN: 2328-8957; E-ISSN: 2328-8957) is a leading open-access journal published by Oxford University Press, dedicated to advancing the field of infectious diseases. Since its inception in 2014, the journal has provided a platform for researchers to disseminate impactful findings in a rapidly evolving domain, achieving a remarkable Q1 ranking in both the Infectious Diseases and Oncology categories as of 2023. The journal encourages rigorous and innovative research, contributing significantly to global health discussions and informing best practices in clinical settings. As an open-access journal, it ensures that its content is accessible to a wide audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. Positioned in the heart of the United States, Open Forum Infectious Diseases serves as a critical resource for the academic community, and its continued commitment to quality and relevance secures its status as an essential publication in the field.

HIV Medicine is a prestigious journal published by Wiley that stands at the forefront of research in the fields of health policy, infectious diseases, and pharmacology, with a commendable impact factor reflected in its Q1 rankings for 2023. Established in 1999 and set to converge its expertise through 2024, this journal plays a critical role in advancing the understanding and treatment of HIV and related health challenges. It is esteemed for its rigorous peer-review process and its contributions to both clinical and policy-oriented discussions surrounding HIV medicine. With a broad international readership, it serves as a vital resource for researchers, healthcare professionals, and students committed to fighting the global HIV epidemic. Although not open access, its vital insights are indispensable for anyone involved in infectious disease research and healthcare policy. Articles published in HIV Medicine shape global health strategies and influence the future of HIV research, making it a must-read for those dedicated to this crucial field.

The Journal of Clinical Virology Plus, published by Elsevier, is an essential resource for researchers and professionals in the fields of virology and infectious diseases. Launched in 2021, this journal aims to bridge the gap between clinical research and application, fostering a deeper understanding of viral pathogenesis, diagnostics, and therapeutic strategies. With an ISSN of 2667-0380, this open-access journal brings cutting-edge findings to the global scientific community, facilitating the rapid dissemination of knowledge critical for advancing public health. Positioned in the Q3 category for both Infectious Diseases and Virology in 2023, its ranking reflects its growing influence and relevance in the academic landscape. The journal strives to support innovative research, collaborative studies, and comprehensive reviews that address contemporary challenges in clinical virology. As it converges through the years from 2021 to 2024, Journal of Clinical Virology Plus aims to be a central hub for vital discussions and breakthroughs in this dynamic field.

AMERICAN JOURNAL OF PREVENTIVE MEDICINE is a premier publication in the fields of Epidemiology and Public Health, published by Elsevier Science Inc. With a commendable impact factor and ranking within the top quartile for both Epidemiology and Public Health categories, this journal serves as a vital source of cutting-edge research, reviews, and critical insights aimed at promoting health and preventing disease. Since its inception in 1985, the journal has been dedicated to disseminating high-quality articles that inform health policy, improve clinical practices, and enhance community health initiatives. It is readily available to researchers and professionals committed to advancing their knowledge and practice, ensuring the continued evolution of preventive medicine. The journal's reach and influence, underscored by its impressive rankings, position it as an essential resource for those looking to make a meaningful impact in the world of preventive health.

MMWR-Morbidity and Mortality Weekly Report, published by the Centers for Disease Control and Prevention (CDC), stands as a preeminent journal in the fields of epidemiology, health information management, and public health. With an impressive reputation bolstered by an H-index reflecting its influence, MMWR is recognized as a Q1 journal as of 2023 across multiple health-related categories. Given its ranking in the 99th percentile among its peers, it provides critical insights and reports that shape health policy and practice globally. The journal is accessed freely by the research community, ensuring that key findings related to morbidity and mortality are widely disseminated and utilized. Established in 1981 and continuing through to 2024, MMWR remains an essential resource for researchers, health professionals, and students dedicated to understanding and combating health issues in the United States and beyond. Its ongoing contributions to the public health dialogue illustrate the journal's pivotal role in promoting health awareness and safety.

JOURNAL OF PUBLIC HEALTH DENTISTRY, published by WILEY, serves as a premier platform for disseminating research and insights critical to the field of public health dentistry. Established in 1941, the journal has adapted to contemporary developments, featuring a convergence of scholarly work that spans from 1941 to 2024. With an ISSN of 0022-4006 and an E-ISSN of 1752-7325, it has garnered recognition within the dental community, holding a Q2 ranking in Dentistry (miscellaneous) and Q3 in Public Health, Environmental, and Occupational Health as of 2023. Researchers and professionals alike can benefit from the journal's commitment to exploring the intricate connections between oral health and public welfare, making it an essential read for those striving to advance knowledge and practice in these interconnected domains. Although it does not offer Open Access, the journal remains highly valuable for those seeking to stay at the forefront of dental public health research, as evidenced by its solid Scopus rankings—positioned at 45/132 in General Dentistry and 264/665 in Public Health. This journal is not just a repository of articles; it is a vital resource for practitioners and academics dedicated to improving oral health outcomes and understanding their broader societal implications.

SEXUALLY TRANSMITTED INFECTIONS is a premier academic journal published by the BMJ PUBLISHING GROUP, dedicated to advancing research in the crucial fields of dermatology and infectious diseases. With a solid impact factor that reflects its quality, this journal occupies a prestigious Q1 category in both dermatology and infectious diseases, indicating its influence and reputation among peers. This journal serves as a vital platform for disseminating research findings, clinical studies, and reviews relevant to sexually transmitted infections, aiming to improve treatment outcomes and public health. Researchers, healthcare professionals, and students will find this journal invaluable for staying informed on the latest developments, trends, and challenges in the field. Available in both print and online formats, SEXUALLY TRANSMITTED INFECTIONS is committed to fostering a deeper understanding and awareness of sexually transmitted diseases globally.

Frontiers in Reproductive Health is a leading open-access journal published by Frontiers Media SA in Switzerland, dedicated to advancing the field of reproductive health through high-quality research and comprehensive reviews. With a commitment to fostering an interdisciplinary dialogue, this journal covers an array of topics including epidemiology, family practice, obstetrics and gynecology, and reproductive medicine. As of 2023, it ranks in the Q3 quartile in Epidemiology, Q1 in Family Practice, and Q2 in both Obstetrics and Gynecology and Reproductive Medicine, reflecting its significance and growing influence in these areas. Researchers and professionals can benefit from the journal's wide distribution and open access policy, which facilitates the sharing of knowledge and enhances the visibility of their work. By embracing innovative studies and harnessing the talents of both established scholars and emerging voices, Frontiers in Reproductive Health plays a crucial role in shaping the future of reproductive health research and practice.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, published by ELSEVIER SCI LTD, stands as a leading platform in the realm of infectious diseases, contributing significantly to the global understanding of this critical field. With an impressive impact factor, the journal maintains a distinguished Q1 ranking across various categories, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, demonstrating its high relevance and influence among contemporary research. Since its inception in 1996, it has embraced an Open Access model, allowing for wider dissemination of essential research findings that can inform public health policies and clinical practices. With a commitment to advancing scientific knowledge, this journal is not only a vital resource for researchers and professionals but also serves as an invaluable educational tool for students interested in the complexities of infectious diseases and their management. For those looking to stay at the forefront of research and innovation in this field, the INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES is an indispensable resource.

CLINICAL MICROBIOLOGY AND INFECTION is a leading journal published by Elsevier Science Ltd, dedicated to advancing the field of infectious diseases and clinical microbiology. With its ISSN 1198-743X and E-ISSN 1469-0691, this esteemed journal has maintained its influential presence since 1995, showcasing high-impact research that addresses critical issues in the diagnosis, treatment, and prevention of infections. Ranked in the Q1 quartile for Infectious Diseases, Medicine (miscellaneous), and Microbiology (medical) categories, and boasting impressive Scopus rankings of #12 and #7 respectively, it sits at the forefront of scientific inquiry in these disciplines. Although it is not an Open Access journal, it provides comprehensive access options for institutions and individuals, ensuring the dissemination of vital research findings. As the field of clinical microbiology continues to evolve, CLINICAL MICROBIOLOGY AND INFECTION remains an essential resource for researchers, clinicians, and students aiming to stay informed on the latest developments and breakthroughs in understanding infectious diseases.